Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1389-1397

  Sette, A D ^a   Oseroff, C ^a   Sidney, J ^a   Alexander, J ^a   Chesnut, R W ^a   Kakimi, K ^a   Guidotti, L G ^a   Chisari, F V ^a  

^a Epimmune   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CYTOTOXICITY; GENE EXPRESSION REGULATION; GENOME IMPRINTING; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0035863924     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1389     Document Type: Article

References (39)

1. The hepatitis B virus
2. Hepatitis B virus immunopathogenesis
3. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection
4. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
5. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a non-cytolytic mechanism in transgenic mice
6. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
7. Viral clearance without destruction of infected cells during acute HBV infection
8. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
9. DNA-mediated immunization in a transgenic mouse model for the hepatitis B surface antigen chronic carrier state
10. Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity
11. Fluorenylmethoxycarbonylpolyamide I solid phase peptide synthesis: General principles and development
12. Several HLA alleles share overlapping peptide specificities
13. Peptide binding to the most frequent HLA-A class 1 alleles measured by quantitative molecular binding assays
14. Prominent role of secondary anchor residues in peptide binding to HLA-A21 molecules
15. Definition of specific peptide motifs for four major HLA-A alleles
16. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins
17. High-level hepatitis B virus replication in transgenic mice
18. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses
19. Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver
20. Access to tissue antigen is restricted in vivo
21. Mechanisms of class 1 restricted immunopathology: A transgenic mouse model of fulminant hepatitis
22. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide transgenic mice
23. The relationship between class 1 binding affinity and immunogenicity of potential cytotoxic T cell epitopes
24. Differences and similiarities in the A21-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice
25. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
26. Identification of A2-restricted hepatits C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome
27. Derivation of HLAA11/Kb transgenic mice: Functional CTL repertoire and recognition of human A11-restricted CTL epitopes
28. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization
29. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: An immunodominant region which induces nonreciprocal CTL cross-reactivity
30. Dissecting the multifactoriai causes of immunodominance in class 1-restricted T cell responses to viruses
31. Lymphocytic choriomeningitis virus
32. Cell mediated immune response to the hepatitis C virus
33. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the anti-viral effects of cytokines
34. Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity
35. Vaccination to treat persistent viral infection
36. + T cells using heterologous prime-boost immunisation strategies
37. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
38. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus
39. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model